Novartis to cut more than 2K jobs in restructuring move

In a global restructuring effort, Swiss drug giant Novartis will cut more than 2,000 jobs, according to The Wall Street Journal.

Advertisement

Most of the job cuts, which will take place through 2022, will affect employees in Switzerland.  The drug giant will eliminate a net 1,000 production jobs and 700 positions in business services. It also plans to cut 400 jobs at a plant in the U.K.

The job reduction is part of CEO Vasant Narasimhan’s plan to shift the company’s efforts from high-volume drugs to personalized medicines, including gene therapies.

Novartis employs 12,800 people in Switzerland.

More articles on pharmacy:
PBM lobby selects new chief with government ties: 5 things to know
AbbVie hit with lawsuit over alleged $1.2B kickback scheme
Reputation save: Novartis links employee bonuses to ethical behavior

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.